GIP/GLP-1 dual receptor agonist-1 (Compound 4) (sodium) is aGIP/GLP-1receptor agonist. GIP/GLP-1 dual receptor agonist-1 (sodium) can be used in the research of metabolic disorders and fatty liver diseases, including nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD).
References:
[1].Brian Lian, et al. Compositions and methods for the treatment of metabolic and liver disorders. WO2022159395.
GIP/GLP-1 dual receptor agonist-1 (Compound 4) (sodium) 是一种GIP/GLP-1受体激动剂。GIP/GLP-1 dual receptor agonist-1 (sodium) 可用于代谢紊乱和脂肪肝疾病的研究,包括非酒精性脂肪性肝炎 (NASH)和非酒精性脂肪性肝病 (NAFLD)。
















